Falk Transformational Research Award
Forecasted
The Falk Transformational Research Award from Health Resources in Action funds advanced translational biomedical research to move discoveries from the lab toward clinical treatments and cures.
Funder: Health Resources in Action
Due Dates (Anticipated): June 2027 (Full application, projected)
Funding Amounts: Up to $1,000,000 total over 2–3 years (inclusive of 10% indirect costs)
Summary: Supports prior Catalyst Awardees with advanced funding to drive translational biomedical research toward new treatments and cures.
Key Information: Only prior Catalyst Award recipients who have met all milestones are eligible to apply.
Description
The Falk Transformational Research Award, administered by Health Resources in Action, is designed to accelerate translational biomedical research stemming from successful Catalyst Award projects. The program provides substantial funding to help researchers overcome critical scientific and therapeutic barriers, aiming to advance promising healthcare innovations closer to commercial development and clinical application. Projects must address unmet needs in identifying disease biomarkers, therapeutic targets, or developing novel therapeutic agents, with a strong emphasis on translational potential and high-impact outcomes for diseases lacking definitive cures.
